羟氯喹已测过N次 － 各国试验结果都一样：无效。
－ 欧盟多国禁止使用羟氯喹治疗新冠患者 英国叫停牛津大学试验 (试验了175个医院，11,000人), 试验的结论是根本没用。
（http://news.cctv.com/2020/05/28/ARTIJsihnQybk9wkdud47BbD200528.shtml ）
－上海市公共卫生临床中心对30例羟氯喹的回顾性分析[2]，发现标准剂量的硫酸羟氯喹（400 mg，1次/d）治疗并未显示出具有改善患者症状、加速病毒学抑制等方面的临床效果。
（https://zhuanlan.zhihu.com/p/112308041）
－New England Journal of Medicine’s study over 1561 patients (who received HCQ) and 3155 patients (who received usual care) shows: patients who received HCQ did not have a lower incidence of death.
( https://www.nejm.org/doi/full/10.1056/NEJMoa2022926 )
伊维菌素也一样：
美国医学会和美国药剂师协会都呼吁了：不要再用这种药治新冠了。
The American Medical Association and American Pharmacist Association have both come out and urged people to not take Ivermectin to treat Covid. (See: https://pharmacist.com/APhA-Press-Releases/ama-apha-ashp-call-for-immediate-end-to-prescribing-dispensing-and-use-of-ivermectin-to-prevent-or-treat-covid-19-outside-clinical-trials )
FDA 还有中文网站，告诉大家为啥不要用这药治新冠。
（https://www.fda.gov/consumers/consumer-updates/weishenmebuyinggaishiyongyiweijunsuzhiliaohuoyufang2019xinguanfeiyan
伊维菌素的制造厂商Merck 都说了：他们这药对新冠没用（＂No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies＂）。
(https://www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/)
